InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Raymon Heather. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. In total, 6 reports have been logged. Activity tracked since 12 September 2024. The latest transaction was disclosed on 15 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Raymon Heather is associated with Artiva Biotherapeutics, Inc. as SVP, Research and Development. He has 6 filings in total, and in the 6 sampled recent filings the recorded transactions are Attribution in nature, with amounts of EUR 3,841.784438979301 and EUR 1,417.755225925519, over the period from 2024-09-13 to 2026-02-18.